speb/financial-data huggingface dataset:
RNAZ cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 51174.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 392000.00
RNAZ income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 172262.00
RNAZ income_statement (quarterly, 2025-03-31) — Diluted EPS: -70.16
RNAZ income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -12085413.00
RNAZ income_statement (quarterly, 2025-03-31) — EBIT: -12085299.00
RNAZ income_statement (quarterly, 2025-03-31) — EBITDA: -12034125.00
RNAZ cash_flow (quarterly, 2025-03-31) — End Cash Position: 11569154.00
RNAZ cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 8854797.00
RNAZ cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3096707.00
RNAZ cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 9234922.00
RNAZ income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -9262110.00
RNAZ income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 951652.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Gross PPE: 362387.00
RNAZ income_statement (quarterly, 2025-03-31) — Interest Expense: 114.00
RNAZ income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 114.00
RNAZ income_statement (quarterly, 2025-03-31) — Interest Income: 146.00
RNAZ income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 146.00
RNAZ cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Invested Capital: 10292698.00
RNAZ cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
RNAZ cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 8854797.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 362387.00
RNAZ cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 8854797.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Income: -12085413.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -12085413.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -12085413.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -12085413.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -12085413.00
RNAZ cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -12085413.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -12085413.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Interest Income: 32.00
RNAZ income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 32.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Net PPE: 38131.00
RNAZ cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 10292698.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 111856.00
RNAZ income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2772015.00
RNAZ income_statement (quarterly, 2025-03-31) — Normalized Income: -2823303.00
RNAZ cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3096707.00
RNAZ cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 9234922.00
RNAZ income_statement (quarterly, 2025-03-31) — Operating Income: -2823335.00
RNAZ income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 833619.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 681184.00
RNAZ income_statement (quarterly, 2025-03-31) — Other Gand A: 951652.00
RNAZ income_statement (quarterly, 2025-03-31) — Other Income Expense: -9262110.00
RNAZ income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -347844.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Other Receivables: 322436.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2509677.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 471614.00
RNAZ income_statement (quarterly, 2025-03-31) — Pretax Income: -12085413.00
RNAZ cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Receivables: 322436.00
RNAZ income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 51174.00
RNAZ income_statement (quarterly, 2025-03-31) — Research And Development: 2219527.00
RNAZ income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -75287329.00
RNAZ income_statement (quarterly, 2025-03-31) — Selling General And Administration: 951652.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Share Issued: 833619.00
RNAZ income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
RNAZ cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 157729.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10292698.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 10292698.00
RNAZ income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RNAZ income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
RNAZ income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Total Assets: 13194375.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10292698.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Total Debt: 0.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10292698.00
RNAZ income_statement (quarterly, 2025-03-31) — Total Expenses: 2823335.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2901677.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 149987.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 392000.00
RNAZ income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3171179.00
RNAZ income_statement (quarterly, 2025-03-31) — Total Unusual Items: -9262110.00
RNAZ income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -9262110.00
RNAZ balance_sheet (quarterly, 2025-03-31) — Working Capital: 10534711.00
RNAZ income_statement (quarterly, 2025-06-30) — +Operating Expense: 4067449.00
RNAZ income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -337698.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 85711453.00
RNAZ income_statement (quarterly, 2025-06-30) — Basic Average Shares: 833654.00
RNAZ income_statement (quarterly, 2025-06-30) — Basic EPS: -5.13
RNAZ cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 11569154.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Capital Stock: 84.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 7374815.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 7374815.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Cash Financial: 7374815.00
RNAZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
RNAZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
RNAZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -4194339.00
RNAZ cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
RNAZ cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 0.00
RNAZ cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -944687.00
RNAZ cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 462014.00
RNAZ cash_flow (quarterly, 2025-06-30) — Change In Receivables: 146314.00
RNAZ cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -224503.00
RNAZ cash_flow (quarterly, 2025-06-30) — Changes In Cash: -4194339.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Common Stock: 84.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6147706.00
RNAZ cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1564990.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Current Assets: 8241721.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1564990.00
RNAZ cash_flow (quarterly, 2025-06-30) — Depreciation: 13442.00
RNAZ cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 13442.00
RNAZ cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 13442.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 553714.00
RNAZ income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 833654.00
RNAZ income_statement (quarterly, 2025-06-30) — Diluted EPS: -5.13
RNAZ income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — EBIT: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — EBITDA: -4263060.00
RNAZ cash_flow (quarterly, 2025-06-30) — End Cash Position: 7374815.00
RNAZ cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
RNAZ cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -4194339.00
RNAZ cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 161714.00
RNAZ income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -209201.00
RNAZ income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1655152.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Gross PPE: 362387.00
RNAZ income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
RNAZ income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
RNAZ income_statement (quarterly, 2025-06-30) — Interest Income: 148.00
RNAZ income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 148.00
RNAZ cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Invested Capital: 6147706.00
RNAZ cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
RNAZ cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 362387.00
RNAZ cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Income: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4276502.00
RNAZ cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4276502.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Interest Income: 148.00
RNAZ income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 148.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Net PPE: 24689.00
RNAZ cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 6147706.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 0.00
RNAZ income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -4053859.00
RNAZ income_statement (quarterly, 2025-06-30) — Normalized Income: -4067301.00
RNAZ cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -4194339.00
RNAZ cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 161714.00
RNAZ income_statement (quarterly, 2025-06-30) — Operating Income: -4067449.00
RNAZ income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 833683.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 297917.00
RNAZ income_statement (quarterly, 2025-06-30) — Other Gand A: 1655152.00
RNAZ income_statement (quarterly, 2025-06-30) — Other Income Expense: -209201.00
RNAZ income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -153685.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Other Receivables: 176122.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1564990.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 392867.00
RNAZ income_statement (quarterly, 2025-06-30) — Pretax Income: -4276502.00
RNAZ cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Receivables: 176122.00
RNAZ income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 13442.00
RNAZ income_statement (quarterly, 2025-06-30) — Research And Development: 2565982.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -79563831.00
RNAZ income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1655152.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Share Issued: 833683.00
RNAZ cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 131510.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6147706.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 6147706.00
RNAZ income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
RNAZ income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Total Assets: 8266410.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 6147706.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Total Debt: 0.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6147706.00
RNAZ income_statement (quarterly, 2025-06-30) — Total Expenses: 4067449.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2118704.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 24689.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 553714.00
RNAZ income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -4221134.00
RNAZ income_statement (quarterly, 2025-06-30) — Total Unusual Items: -209201.00
RNAZ income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -209201.00
RNAZ balance_sheet (quarterly, 2025-06-30) — Working Capital: 6676731.00
RNAZ income_statement (quarterly, 2025-09-30) — +Operating Expense: 4539026.00
RNAZ income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -342479.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 85845777.00
RNAZ income_statement (quarterly, 2025-09-30) — Basic Average Shares: 834373.00
RNAZ income_statement (quarterly, 2025-09-30) — Basic EPS: -5.82
RNAZ cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 7374815.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Capital Stock: 84.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2835916.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2835916.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Cash Financial: 2835916.00
RNAZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -455726.00
RNAZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
RNAZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -4083173.00
RNAZ cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 0.00
RNAZ cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
RNAZ cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 0.00
RNAZ cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1402837.00
RNAZ cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1026051.00
RNAZ cash_flow (quarterly, 2025-09-30) — Change In Receivables: -22174.00
RNAZ cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 354612.00
RNAZ cash_flow (quarterly, 2025-09-30) — Changes In Cash: -4538899.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Common Stock: 84.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1425979.00
RNAZ cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2967828.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Current Assets: 4751048.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2967828.00
RNAZ cash_flow (quarterly, 2025-09-30) — Depreciation: 4781.00
RNAZ cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 4781.00
RNAZ cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 4781.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 832875.00
RNAZ income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 834373.00
RNAZ income_statement (quarterly, 2025-09-30) — Diluted EPS: -5.82
RNAZ income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -4856051.00
RNAZ income_statement (quarterly, 2025-09-30) — EBIT: -4850091.00
RNAZ income_statement (quarterly, 2025-09-30) — EBITDA: -4845310.00
RNAZ cash_flow (quarterly, 2025-09-30) — End Cash Position: 2835916.00
RNAZ cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -455726.00
RNAZ cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -4083173.00
RNAZ cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 279161.00
RNAZ income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -311212.00
RNAZ income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1400136.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Gross PPE: 362387.00
RNAZ income_statement (quarterly, 2025-09-30) — Interest Expense: 5960.00
RNAZ income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5960.00
RNAZ income_statement (quarterly, 2025-09-30) — Interest Income: 147.00
RNAZ income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 147.00
RNAZ cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 5960.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1425979.00
RNAZ cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
RNAZ cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 362387.00
RNAZ cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Income: -4856051.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -4856051.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -4856051.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -4856051.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -4856051.00
RNAZ cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -4856051.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -4856051.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Interest Income: -5813.00
RNAZ income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -5813.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Net PPE: 19908.00
RNAZ cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1425979.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 455726.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 0.00
RNAZ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -4534098.00
RNAZ income_statement (quarterly, 2025-09-30) — Normalized Income: -4544839.00
RNAZ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -4083173.00
RNAZ cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 279161.00
RNAZ income_statement (quarterly, 2025-09-30) — Operating Income: -4539026.00
RNAZ income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 833683.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1340188.00
RNAZ income_statement (quarterly, 2025-09-30) — Other Gand A: 1400136.00
RNAZ income_statement (quarterly, 2025-09-30) — Other Income Expense: -311212.00
RNAZ income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -22174.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Other Receivables: 198296.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2967828.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 376648.00
RNAZ income_statement (quarterly, 2025-09-30) — Pretax Income: -4856051.00
RNAZ cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Receivables: 198296.00
RNAZ income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 4781.00
RNAZ income_statement (quarterly, 2025-09-30) — Research And Development: 3161064.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -84419882.00
RNAZ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1400136.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Share Issued: 833683.00
RNAZ cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 134324.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1425979.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1425979.00
RNAZ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
RNAZ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Total Assets: 5226682.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1425979.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Total Debt: 0.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1425979.00
RNAZ income_statement (quarterly, 2025-09-30) — Total Expenses: 4539026.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3800703.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 475634.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 832875.00
RNAZ income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4561200.00
RNAZ income_statement (quarterly, 2025-09-30) — Total Unusual Items: -311212.00
RNAZ income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -311212.00
RNAZ balance_sheet (quarterly, 2025-09-30) — Working Capital: 1783220.00
RNAZ income_statement (annual, 2025-12-31) — +Operating Expense: 17915044.00
RNAZ income_statement (quarterly, 2025-12-31) — +Operating Expense: 6485234.00
RNAZ income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
RNAZ income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -387260.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -387260.00
RNAZ balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 108198366.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 108198366.00
RNAZ income_statement (annual, 2025-12-31) — Basic Average Shares: 689713.00
RNAZ income_statement (annual, 2025-12-31) — Basic EPS: -52.59
RNAZ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 5811064.00
RNAZ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2835916.00
RNAZ cash_flow (annual, 2025-12-31) — Capital Expenditure: -6660.00
RNAZ balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Capital Stock: 141544628.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 141544628.00
RNAZ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 17813521.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 17813521.00
RNAZ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17813521.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17813521.00
RNAZ balance_sheet (annual, 2025-12-31) — Cash Financial: 17813521.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Cash Financial: 17813521.00
RNAZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 31523122.00
RNAZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 23124051.00
RNAZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4436.00
RNAZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4436.00
RNAZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -19516229.00
RNAZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -8142010.00
RNAZ cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 111856.00
RNAZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 0.00
RNAZ cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -38291.00
RNAZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
RNAZ cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 200660.00
RNAZ cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 226068.00
RNAZ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 216541.00
RNAZ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -43150.00
RNAZ cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 477261.00
RNAZ cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 911823.00
RNAZ cash_flow (annual, 2025-12-31) — Change In Receivables: -952460.00
RNAZ cash_flow (quarterly, 2025-12-31) — Change In Receivables: -754164.00
RNAZ cash_flow (annual, 2025-12-31) — Change In Working Capital: 15567.00
RNAZ cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 340577.00
RNAZ cash_flow (annual, 2025-12-31) — Changes In Cash: 12002457.00
RNAZ cash_flow (quarterly, 2025-12-31) — Changes In Cash: 14977605.00
RNAZ balance_sheet (annual, 2025-12-31) — Common Stock: 92.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Common Stock: 92.00
RNAZ balance_sheet (annual, 2025-12-31) — Common Stock Equity: 10335466.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 10335466.00
RNAZ cash_flow (annual, 2025-12-31) — Common Stock Issuance: 8854798.00
RNAZ cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1.00
RNAZ balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 3494220.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3494220.00
RNAZ balance_sheet (annual, 2025-12-31) — Current Assets: 21983865.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Current Assets: 21983865.00
RNAZ balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 0.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 0.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Current Liabilities: 3494220.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3494220.00
RNAZ cash_flow (annual, 2025-12-31) — Depreciation: 114177.00
RNAZ cash_flow (quarterly, 2025-12-31) — Depreciation: 44780.00
RNAZ cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 114177.00
RNAZ cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 44780.00
RNAZ cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 114177.00
RNAZ cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 44780.00
RNAZ balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 434399.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 434399.00
RNAZ income_statement (annual, 2025-12-31) — Diluted Average Shares: 689713.00
RNAZ income_statement (annual, 2025-12-31) — Diluted EPS: -52.59
RNAZ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -36271287.00
RNAZ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -15053321.00
RNAZ balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 638.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 638.00
RNAZ income_statement (annual, 2025-12-31) — EBIT: -34428392.00
RNAZ income_statement (quarterly, 2025-12-31) — EBIT: -13216500.00
RNAZ income_statement (annual, 2025-12-31) — EBITDA: -34314215.00
RNAZ income_statement (quarterly, 2025-12-31) — EBITDA: -13171720.00
RNAZ cash_flow (annual, 2025-12-31) — End Cash Position: 17813521.00
RNAZ cash_flow (quarterly, 2025-12-31) — End Cash Position: 17813521.00
RNAZ cash_flow (annual, 2025-12-31) — Financing Cash Flow: 31523122.00
RNAZ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 23124051.00
RNAZ cash_flow (annual, 2025-12-31) — Free Cash Flow: -19522889.00
RNAZ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -8148670.00
RNAZ cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 9277321.00
RNAZ cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -398476.00
RNAZ income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
RNAZ income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -9389386.00
RNAZ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 393137.00
RNAZ income_statement (annual, 2025-12-31) — General And Administrative Expense: 5771063.00
RNAZ income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1764122.00
RNAZ balance_sheet (annual, 2025-12-31) — Goodwill: 25744143.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Goodwill: 25744143.00
RNAZ balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 140044143.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 140044143.00
RNAZ balance_sheet (annual, 2025-12-31) — Gross PPE: 757941.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Gross PPE: 757941.00
RNAZ income_statement (annual, 2025-12-31) — Interest Expense: 6616.00
RNAZ income_statement (quarterly, 2025-12-31) — Interest Expense: 542.00
RNAZ income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 6616.00
RNAZ income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 542.00
RNAZ income_statement (annual, 2025-12-31) — Interest Income: 79198.00
RNAZ income_statement (quarterly, 2025-12-31) — Interest Income: 78757.00
RNAZ income_statement (annual, 2025-12-31) — Interest Income Non Operating: 79198.00
RNAZ income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 78757.00
RNAZ cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 6501.00
RNAZ cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 541.00
RNAZ balance_sheet (annual, 2025-12-31) — Invested Capital: 10335466.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Invested Capital: 10335466.00
RNAZ cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4436.00
RNAZ cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4436.00
RNAZ cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 31523122.00
RNAZ cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 22668325.00
RNAZ balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 757941.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 757941.00
RNAZ cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 2224.00
RNAZ cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 8854798.00
RNAZ cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1.00
RNAZ income_statement (annual, 2025-12-31) — Net Income: -34661076.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Income: -13443110.00
RNAZ income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -36271287.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -15053321.00
RNAZ income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -34661076.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -13443110.00
RNAZ income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -34661076.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -13443110.00
RNAZ income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -34661076.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -13443110.00
RNAZ cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -34661076.00
RNAZ cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -13443110.00
RNAZ income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -34661076.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -13443110.00
RNAZ income_statement (annual, 2025-12-31) — Net Interest Income: 72582.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Interest Income: 78215.00
RNAZ income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 72582.00
RNAZ income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 78215.00
RNAZ balance_sheet (annual, 2025-12-31) — Net PPE: 370681.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Net PPE: 370681.00
RNAZ cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -6660.00
RNAZ cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -6660.00
RNAZ cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 22668324.00
RNAZ balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 11835859.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 11835859.00
RNAZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 226068.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 226068.00
RNAZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 226068.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 226068.00
RNAZ balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 0.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 0.00
RNAZ income_statement (annual, 2025-12-31) — Normalized EBITDA: -17721669.00
RNAZ income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -6361697.00
RNAZ income_statement (annual, 2025-12-31) — Normalized Income: -21552964.66
RNAZ income_statement (quarterly, 2025-12-31) — Normalized Income: -6633087.00
RNAZ cash_flow (annual, 2025-12-31) — Operating Cash Flow: -19516229.00
RNAZ cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -8142010.00
RNAZ cash_flow (annual, 2025-12-31) — Operating Gains Losses: 9277321.00
RNAZ cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -398476.00
RNAZ income_statement (annual, 2025-12-31) — Operating Income: -17915044.00
RNAZ income_statement (quarterly, 2025-12-31) — Operating Income: -6485234.00
RNAZ income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
RNAZ income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 916968.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 916968.00
RNAZ balance_sheet (annual, 2025-12-31) — Other Current Assets: 2826846.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2826846.00
RNAZ income_statement (annual, 2025-12-31) — Other Gand A: 5771063.00
RNAZ income_statement (quarterly, 2025-12-31) — Other Gand A: 1764122.00
RNAZ income_statement (annual, 2025-12-31) — Other Income Expense: -16592546.00
RNAZ income_statement (quarterly, 2025-12-31) — Other Income Expense: -6810023.00
RNAZ balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 114300000.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 114300000.00
RNAZ cash_flow (annual, 2025-12-31) — Other Non Cash Items: 5252354.00
RNAZ balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 6364000.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 6364000.00
RNAZ income_statement (annual, 2025-12-31) — Other Operating Expenses: -1277867.00
RNAZ income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -754163.00
RNAZ balance_sheet (annual, 2025-12-31) — Other Receivables: 952460.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Other Receivables: 952460.00
RNAZ income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3494220.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3494220.00
RNAZ balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 141544536.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 141544536.00
RNAZ balance_sheet (annual, 2025-12-31) — Preferred Stock: 141544536.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 141544536.00
RNAZ income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 1610211.00
RNAZ balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 141544536.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 141544536.00
RNAZ cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 22668324.00
RNAZ balance_sheet (annual, 2025-12-31) — Prepaid Assets: 390400.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 390400.00
RNAZ income_statement (annual, 2025-12-31) — Pretax Income: -34435008.00
RNAZ income_statement (quarterly, 2025-12-31) — Pretax Income: -13217042.00
RNAZ cash_flow (annual, 2025-12-31) — Purchase Of PPE: -6660.00
RNAZ cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -6660.00
RNAZ balance_sheet (annual, 2025-12-31) — Receivables: 953098.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Receivables: 953098.00
RNAZ income_statement (annual, 2025-12-31) — Reconciled Depreciation: 114177.00
RNAZ income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 44780.00
RNAZ income_statement (annual, 2025-12-31) — Research And Development: 13421848.00
RNAZ income_statement (quarterly, 2025-12-31) — Research And Development: 5475275.00
RNAZ income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 7203160.00
RNAZ balance_sheet (annual, 2025-12-31) — Retained Earnings: -97862992.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -97862992.00
RNAZ cash_flow (annual, 2025-12-31) — Sale Of Business: 2224.00
RNAZ income_statement (annual, 2025-12-31) — Selling General And Administration: 5771063.00
RNAZ income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1764122.00
RNAZ balance_sheet (annual, 2025-12-31) — Share Issued: 916968.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Share Issued: 916968.00
RNAZ income_statement (annual, 2025-12-31) — Special Income Charges: -7203160.00
RNAZ cash_flow (annual, 2025-12-31) — Stock Based Compensation: 485428.00
RNAZ cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 61865.00
RNAZ balance_sheet (annual, 2025-12-31) — Stockholders Equity: 151880002.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 151880002.00
RNAZ balance_sheet (annual, 2025-12-31) — Tangible Book Value: -129708677.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -129708677.00
RNAZ income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -3484434.66
RNAZ income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
RNAZ income_statement (annual, 2025-12-31) — Tax Provision: 226068.00
RNAZ income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
RNAZ income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Total Assets: 162398689.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Total Assets: 162398689.00
RNAZ balance_sheet (annual, 2025-12-31) — Total Capitalization: 151880002.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 151880002.00
RNAZ balance_sheet (annual, 2025-12-31) — Total Debt: 0.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Total Debt: 0.00
RNAZ balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 151880002.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 151880002.00
RNAZ income_statement (annual, 2025-12-31) — Total Expenses: 17915044.00
RNAZ income_statement (quarterly, 2025-12-31) — Total Expenses: 6485234.00
RNAZ balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 10518687.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 10518687.00
RNAZ balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 140414824.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 140414824.00
RNAZ balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 7024467.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 7024467.00
RNAZ income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -27980071.00
RNAZ income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -16026557.00
RNAZ income_statement (annual, 2025-12-31) — Total Unusual Items: -16592546.00
RNAZ income_statement (quarterly, 2025-12-31) — Total Unusual Items: -6810023.00
RNAZ income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -16592546.00
RNAZ income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -6810023.00
RNAZ balance_sheet (annual, 2025-12-31) — Working Capital: 18489645.00
RNAZ balance_sheet (quarterly, 2025-12-31) — Working Capital: 18489645.00
RNAZ income_statement (quarterly, 2026-03-31) — +Operating Expense: 17615194.00
RNAZ income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -411196.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 116899277.00
RNAZ income_statement (quarterly, 2026-03-31) — Basic Average Shares: 916968.00
RNAZ income_statement (quarterly, 2026-03-31) — Basic EPS: -21.28
RNAZ cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 17813521.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Capital Stock: 143269974.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 12835454.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 12835454.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Cash Financial: 12835454.00
RNAZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 0.00
RNAZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4978067.00
RNAZ cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 0.00
RNAZ cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 316571.00
RNAZ cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1774088.00
RNAZ cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -695656.00
RNAZ cash_flow (quarterly, 2026-03-31) — Change In Receivables: 952460.00
RNAZ cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2347463.00
RNAZ cash_flow (quarterly, 2026-03-31) — Changes In Cash: -4978067.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Common Stock: 92.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1251306.00
RNAZ cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 5293308.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Current Assets: 16748994.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 85262.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 85262.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5378570.00
RNAZ cash_flow (quarterly, 2026-03-31) — Depreciation: 23936.00
RNAZ cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 23936.00
RNAZ cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 23936.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 559747.00
RNAZ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 916968.00
RNAZ income_statement (quarterly, 2026-03-31) — Diluted EPS: -21.28
RNAZ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -19510296.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 638.00
RNAZ income_statement (quarterly, 2026-03-31) — EBIT: -17553762.00
RNAZ income_statement (quarterly, 2026-03-31) — EBITDA: -17529826.00
RNAZ cash_flow (quarterly, 2026-03-31) — End Cash Position: 12835454.00
RNAZ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 0.00
RNAZ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4978067.00
RNAZ cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 125348.00
RNAZ income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -146456.00
RNAZ income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2221823.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Goodwill: 25744143.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 140044143.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Gross PPE: 757941.00
RNAZ income_statement (quarterly, 2026-03-31) — Interest Expense: 0.00
RNAZ income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 0.00
RNAZ income_statement (quarterly, 2026-03-31) — Interest Income: 91888.00
RNAZ income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 91888.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1251306.00
RNAZ cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
RNAZ balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 757941.00
RNAZ cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
RNAZ income_statement (quarterly, 2026-03-31) — Net Income: -17785071.00
RNAZ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -19510296.00
RNAZ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -17785071.00
RNAZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -17785071.00
RNAZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -17785071.00
RNAZ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -17785071.00